tirzepatide breast cancer study as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial Tirzepatide reduces breast cancer growth

P., Gianaroli, L., Biagiotti, G., and Vitali, G

However, these treatments are costly, leading to equity issues with access to therapy

Shedrx is a telehealth platform connecting patients with physicians for compounded GLP-1 prescriptions and monthly monitoring

The Results In this study, 3,346 people with obesity, meaning a BMI over 30, but without diabetes started GLP-1 therapy and were compared to 8,343 similar people not using GLP-1 drugs

But its important to understand that while semaglutides primary function is to regulate blood sugar and aid in weight loss, these secondary effects on hormones like testosterone are under continuous study

For many peopleespecially those over 50 or with common genetic mutationsthat conversion process is inefficient, meaning you're not getting the benefits you paid for